Malaria

In 2018 Malaria killed approximately 400,000 people, mostly in Sub-Saharan Africa.

Malaria has been highly resistant to vaccination, and to the development of consistent protocols for the disease. 

While this is an upcoming project, it would be Flood Biotech’s goal to provide a baseline of vaccine candidates, and then to computationally assess each year the variations and mutations which make Malaria such a persistent problem.

By providing this baseline and by continually updating a potential range of vaccine candidates — we hope to aid in the eradication of Malaria worldwide.

This is an upcoming project.

Please see our other projects: Covid-19 and Tuberculosis.